• 13 DE
• 14 EN

• 9 Home
• 10 Contact
• 11 Sitemap

• 5.1 CNS & Alzheimer's
  • 5.1.1 Alzheimer’s
  • 5.1.2 Depression
  • 5.1.3 Dystonia
  • 5.1.4 Parkinson’s

• 5.2 Dermatology
  • 5.2.1Hair loss
  • 5.2.2Scars
  • 5.2.4Acne

• 5.3 Metabolism
  • 5.3.1Liver Disease
  • 5.3.2Lipid Metabolism

• 5.4 Self medication
  • 5.4.1Bladder & Prostate
  • 5.4.2Cholesterol
  • 5.4.3Shower Products
  • 5.4.4Emotional Balance
  • 5.4.5Cold Remedies
  • 5.4.6Health Care Baths
  • 5.4.7Skin, Hair, and Nails
  • 5.4.8Cognitive Ability
  • 5.4.9Stomach, Liver, and Gallbladder
  • 5.4.10Muscles & Joints
  • 5.4.11Vitamins & Minerals

Alzheimer’s Disease

Alzheimer’s Disease is the most common form of dementia. The number of Alzheimer patients is estimated to be approximately 850,000 in Germany, four million in the USA, 15 million worldwide, and the number of Alzheimer patients will grow exponentially in the future.

Merz is a leader in the field of Alzheimer research and developed the first drug approved for the treatment of moderate to severe Alzheimer’s disease. Memantine is widely available in Europe, US, South America, Canada, Australia and selected Asian markets.

Be informed:

Professionals will find detailed information at www.axura.info.

Citizens of the US will find specific information at www.namenda.com.

To promote scientific research work Merz annually presents

• the Award for Brain Research
• the Friedrich-Merz Visiting Professorship

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

German Websites

• Alzheimer´s
• Depression
• Dystonia
• Hair Loss
• Hyal-System
• Liver Disease
• Parkinson´s

Quick-Links